Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Metformin hydrochloride prices in Germany, the highest-cost reporting region, rose 6.3% in H1 2026, climbing from USD 14.3/KG in Q1 to USD 15.2/KG by Q2 as firmer dimethylamine and dicyandiamide synthesis intermediate costs and accelerating global diabetes management pharmaceutical demand drove consistent buying. Globally, the average rose from USD 9.06/KG in Q1 to USD 9.60/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 9.72-10.68/KG is expected, with continued firming on supply disruptions and growing type 2 diabetes and metabolic syndrome management sector demand.
Metformin hydrochloride is the most widely prescribed oral antidiabetic medication globally, produced through a condensation reaction between dimethylamine and 2-cyanoguanidine, commonly known as dicyandiamide, under controlled temperature and pressure conditions. The resulting biguanide active pharmaceutical ingredient is converted to the hydrochloride salt form for enhanced water solubility and formulation stability. China and India together account for the majority of global metformin hydrochloride API production, supported by abundant domestic dicyandiamide supply from calcium carbide and cyanamide chemistry. The largest pull comes from pharmaceutical tablet and extended-release formulations for the first-line treatment of type 2 diabetes mellitus, where metformin reduces hepatic glucose production, improves insulin sensitivity, and supports modest weight reduction without hypoglycaemia risk. Additional demand comes from combination tablet products pairing metformin with newer antidiabetic agents including DPP-4 inhibitors, SGLT-2 inhibitors, and GLP-1 receptor agonists, polycystic ovary syndrome management, pre-diabetes intervention programmes, and emerging research into metformin’s potential cancer prevention and anti-ageing applications. Dimethylamine and dicyandiamide synthesis intermediate costs, type 2 diabetes prevalence trends, and regional API production capacity all feed into the price.
The balance of supply and demand for metformin hydrochloride through H2 2026 leans moderately firm. Dimethylamine and dicyandiamide synthesis intermediate costs firmed from Middle East and agricultural supply chain disruptions. Type 2 diabetes management pharmaceutical demand is growing strongly with expanding global diabetes prevalence, driven by sedentary lifestyles and rising obesity rates across developing and developed markets.
The main upside risk is a sustained synthesis intermediate cost increase alongside accelerating diabetes prevalence and combination product demand. The main downside risk is continued Chinese metformin API surplus production and competitive generic pharmaceutical pricing that limits global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 9.72 - 10.68 | Synthesis cost firming and diabetes demand support |
| United States | 10.36 - 11.32 | Steady diabetes and PCOS demand holds it firm |
| China | 6.50 - 7.46 | Large API capacity keeps it the most affordable |
| Germany | 14.62 - 15.58 | High synthesis and energy costs keep it the most expensive |
| India | 10.24 - 11.20 | Growing diabetes management demand holds a firm middle |
US metformin hydrochloride prices averaged USD 11.5/KG in Q2 2026, up 6.5% from USD 10.8/KG in Q1 2026. Firmer dimethylamine and dicyandiamide synthesis intermediate costs and accelerating diabetes management and combination product procurement drove consistent buying through the quarter.
Why did the price of Metformin Hydrochloride change in Q2 2026 in the United States?
Firmer dimethylamine and dicyandiamide synthesis intermediate costs raised the API production cost floor. Type 2 diabetes first-line therapy and combination product formulation procurement lifted buying from API suppliers. Polycystic ovary syndrome and pre-diabetes management demand provided additional consistent buying support.
Chinese metformin hydrochloride prices averaged USD 7.2/KG in Q2 2026, up 5.9% from USD 6.8/KG in Q1 2026, the lowest among the tracked markets. Spring pharmaceutical export and domestic diabetes management procurement lifted buying. Firmer domestic synthesis intermediate costs raised the production floor despite large domestic API capacity.
Why did the price of Metformin Hydrochloride change in Q2 2026 in China?
Spring diabetes pharmaceutical export and domestic formulation procurement lifted buying from domestic API producers. Firmer domestic dimethylamine and dicyandiamide costs raised the production cost floor. Large domestic API capacity kept China the most affordable source.
German metformin hydrochloride prices averaged USD 15.2/KG in Q2 2026, up 6.3% from USD 14.3/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Consistent diabetes first-line therapy, polycystic ovary syndrome, and combination product demand maintained consistent buying.
Why did the price of Metformin Hydrochloride change in Q2 2026 in Germany?
Higher dimethylamine synthesis intermediate and energy costs elevated European API production economics. Middle East supply disruptions added cost premiums to intermediate supply chains. Consistent type 2 diabetes, polycystic ovary syndrome, and combination tablet demand maintained consistent pharmaceutical procurement.
Indian metformin hydrochloride prices averaged USD 10.7/KG in Q2 2026, up 5.9% from USD 10.1/KG in Q1 2026. Growing type 2 diabetes and polycystic ovary syndrome management demand supported buying. Firmer import-linked synthesis intermediate costs raised the production floor through the quarter.
Why did the price of Metformin Hydrochloride change in Q2 2026 in India?
Growing type 2 diabetes and polycystic ovary syndrome management demand lifted procurement from domestic API and formulation producers. Firmer synthesis intermediate costs raised the production floor. Export demand from Southeast Asian and African markets provided additional buying support.
US metformin hydrochloride prices averaged USD 10.8/KG in Q1 2026, recovering on the quarter. Diabetes management and combination product demand and firming synthesis costs held the market near USD 10.8/KG.
Why did the price of Metformin Hydrochloride change in Q1 2026 in the United States?
Type 2 diabetes management and combination product procurement maintained buying. Firmer synthesis intermediate costs held the production floor. The market recovered from the Q3 2025 API softness near USD 10.8/KG.
Chinese prices averaged USD 6.8/KG in Q1 2026, recovering on the quarter. Post-Lunar New Year diabetes pharmaceutical restocking and firmer synthesis costs held the market near USD 6.8/KG.
Why did the price of Metformin Hydrochloride change in Q1 2026 in China?
Post-Lunar New Year diabetes pharmaceutical restocking lifted buying. Firmer dimethylamine and dicyandiamide costs raised the production floor. The market recovered to USD 6.8/KG from the Q3 2025 level.
German prices averaged USD 14.3/KG in Q1 2026, recovering on the quarter. Diabetes therapy and combination product demand and firm synthesis and energy costs held the market near USD 14.3/KG.
Why did the price of Metformin Hydrochloride change in Q1 2026 in Germany?
Type 2 diabetes and combination product demand maintained buying. Firm synthesis intermediate and energy costs held the elevated production floor. The market recovered to USD 14.3/KG from the Q3 2025 API softness.
Indian prices averaged USD 10.1/KG in Q1 2026, recovering on the quarter. Growing diabetes and polycystic ovary syndrome demand and firmer synthesis costs held the market near USD 10.1/KG.
Why did the price of Metformin Hydrochloride change in Q1 2026 in India?
Growing diabetes management and polycystic ovary syndrome demand maintained buying. Firmer synthesis intermediate costs raised the production floor. The market recovered to USD 10.1/KG from the Q3 2025 level.
Global metformin hydrochloride prices dipped briefly in Q3 2025 on seasonal API synthesis softness before recovering steadily through Q4 2025, Q1 2026, and Q2 2026. The average eased from USD 8.80/KG in Q2 2025 to USD 8.71/KG in Q3, then firmed to USD 8.88/KG in Q4, USD 9.06/KG in Q1 2026, and USD 9.60/KG in Q2 2026, a net gain of about 9.1% over the window. Synthesis intermediate cost cycles and growing diabetes management demand drove the consistent recovery.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 9.60 | +6.0% | ↑ Rising |
| Q1 2026 | 9.06 | +2.0% | ↑ Rising |
| Q4 2025 | 8.88 | +2.0% | ↑ Rising |
| Q3 2025 | 8.71 | -1.0% | ↓ Falling |
| Q2 2025 | 8.80 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Metformin hydrochloride prices followed a broadly firming path through 2025 after the brief Q3 API synthesis softening. The global average opened at USD 8.72/KG in Q1 2025 and closed near USD 8.88/KG in Q4, a full-year gain of about 1.8%. Consistent diabetes management demand and synthesis intermediate cost dynamics drove the quarterly pattern.
US prices firmed from about USD 10.2/KG in Q1 2025 to USD 10.5/KG by Q4, a gain of 2.9%. Consistent type 2 diabetes and polycystic ovary syndrome management demand supported the upward trend.
Chinese prices fell from roughly USD 6.8/KG in Q1 2025 to USD 6.6/KG by Q4, a decline of 2.9%. Large domestic API production capacity and competitive export pricing maintained the lowest price level.
German prices firmed from about USD 13.5/KG in Q1 2025 to USD 13.9/KG by Q4, a gain of 3.0%. Consistent diabetes first-line therapy and combination product demand and firm synthesis and energy costs supported the market throughout the year.
Indian prices firmed from roughly USD 9.5/KG in Q1 2025 to USD 9.8/KG by Q4, a gain of 3.2%, the strongest in the dataset. Growing domestic and export diabetes management demand drove the consistent firming through the year.
Expert Market Research: Your Source for Real-Time Metformin Hydrochloride Price Intelligence
Expert Market Research tracks metformin hydrochloride prices continuously across every major producing and consuming region. The team traces causation through dimethylamine and dicyandiamide synthesis intermediate economics, diabetes management pharmaceutical demand trends, and regional API production capacity. Contact Expert Market Research today for metformin hydrochloride pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Pharmaceutical tablet and extended-release formulations for the first-line treatment of type 2 diabetes mellitus take the largest and fastest-growing share. Combination products with DPP-4 inhibitors, SGLT-2 inhibitors, and GLP-1 receptor agonists, polycystic ovary syndrome management, pre-diabetes intervention, and emerging anti-ageing research also drive significant demand.
The Q2 2026 average was USD 11.5/KG in the United States, USD 7.2/KG in China, USD 15.2/KG in Germany, and USD 10.7/KG in India. Germany remains the highest-priced market.
The global average rose from USD 9.06/KG in Q1 to about USD 9.60/KG in Q2, a gain of around 6.0%. Firmer synthesis intermediate costs and accelerating diabetes management demand drove the H1 firming.
Seasonal API synthesis softness and post-season pharmaceutical procurement moderation reduced buying urgency. Soft dimethylamine feedstock costs eased the production cost floor before the Q4 2025 recovery.
The global average is expected in the USD 9.72 to 10.68/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and global type 2 diabetes prevalence continues growing.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on diabetes and polycystic ovary syndrome demand, and China prices lowest on large domestic API capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to dimethylamine and dicyandiamide synthesis intermediate costs, diabetes prevalence growth trends, and generic pharmaceutical market competition. Chinese API production discipline and calcium carbide feedstock costs are key signals.
Asia Pacific leads with China and India holding the largest metformin API synthesis capacity, followed by Europe. Any dimethylamine or dicyandiamide cost shift ripples across markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time diabetes formulation contracts around API production cycles, build cover when dicyandiamide signals tightening, and monitor Chinese API output as the primary supply signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.